Retro Biosciences
Retro develops therapies aimed at reversing diseases related to aging by focusing on cellular reprogramming and autophagy. They seek to build a pioneering genomics platform to support their innovative research on rejuvenating cells and tissues, with an emphasis on collaboration across experimental, automation, and computational sciences.
Retro Bio is a mission-driven biotechnology company focused on extending healthy human lifespan by 10 years. They develop therapeutics that target core aging processes, combining deep biology with data-driven discovery and translational research to advance candidate interventions toward the clinic. Retro Bio collaborates across academia and industry and builds interdisciplinary teams to accelerate programs that delay or reverse age-related decline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Retro Biosciences.
Retro Biosciences didn’t post a salary, so this is our estimate from similar listings.
Retro Diet Coke Lime Returns for Limited Nationwide Run
Oct 8, 2025
Immunology Senior Research Scientist - Single-Cell Genomics
Vertex
Postdoctoral position in single-cell functional genomics, Norman Lab
Memorial Sloan Kettering Cancer Center
Director, Clinical Genomics & Molecular Assay Development
Bristol Myers Squibb
Postdoctoral Research Associate, Cellular and Molecular Medicine
RYAN WHITE
Senior Research Associate, Single Cell Technology
NewLimit
Postdoctoral Fellow, Functional Genomics
Biohub